A Phase 2 trial (Obesity Research, 2004) found 12 weeks of subcutaneous AOD-9604 produced statistically significant abdominal fat reduction versus placebo without altering fasting glucose or insulin levels
Compounded preparations of this nature are not subject to the same rigorous quality, safety, and efficacy standards as licensed medicines
You may also notice an improvement in coordination and balance
These are symptoms of pernicious anemia, which occurs when the body doesnt have enough vitamin B12 to support healthy red blood cell production (NIH-b, 2021)
human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved